HomeNDC LookupRxCUI directory › RxCUI 606859

Paricalcitol 0.002 MG Oral Capsule [Zemplar] — RxCUI 606859

RxNorm drug concept · Semantic branded drug
RxCUI 606859 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI606859
Official nameParicalcitol 0.002 MG Oral Capsule [Zemplar]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZemplar 2 MCG Oral Capsule; Zemplar 0.002 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)18 prescriptions · 1 state & territory Medicaid programs · latest period Q3 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Paricalcitol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Paricalcitol isn't repairing your kidneys directly — what it's doing is fixing a problem caused by kidney disease. When your kidneys are damaged, they can't activate vitamin D the...
  • What exactly is paricalcitol doing for my kidneys?
  • High calcium — called hypercalcemia — can sneak up on you, but there are signs to watch for: feeling unusually tired or weak, trouble thinking clearly, loss of appetite, nausea, vo...
  • How will I know if my calcium gets too high while I'm on this medication?
📖 Read our full Paricalcitol guide →

🕸️ Concept Web — How Paricalcitol 0.002 MG Oral Capsule [Zemplar] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Paricalcitol 0.002 MG Oral Capsule [Zemplar] RxCUI 606859

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Paricalcitol 73710
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zemplar 221005
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Paricalcitol Oral Capsule 577314
    • Paricalcitol Oral Product 1161357
    • Paricalcitol Pill 1161358
    • Paricalcitol Oral Capsule [Zemplar] 606853
    • Zemplar Oral Product 1187240
    • Zemplar Pill 1187241
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Paricalcitol 0.002 MG Oral Capsule SCD · 577317
  • Paricalcitol 0.002 MG SCDC · 577316
  • Paricalcitol Oral Capsule SCDF · 577314
  • Paricalcitol Oral Product SCDG · 1161357
  • Paricalcitol Pill SCDG · 1161358

Brand-Name Concepts

  • Paricalcitol 0.002 MG [Zemplar] SBDC · 606858
  • Paricalcitol Oral Capsule [Zemplar] SBDF · 606853
  • Zemplar Oral Product SBDG · 1187240
  • Zemplar Pill SBDG · 1187241
  • Zemplar BN · 221005

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 606859 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00074-9036-30 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-9036-30) Zemplar AbbVie Inc. 2018-04-20
00074-9037-30 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-9037-30) Zemplar AbbVie Inc. 2018-04-20
Observed labelers: AbbVie Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.